Cuprina Holdings (Cayman) LTD (CUPR) stock
Close on Nov 12, 2026Market cap $12.37MP/E –Yield –
Cuprina Holdings (Cayman) LTD grew revenue 3.3% to 49.89K SGD over fiscal 2025. Free cash flow was -9.19M SGD. At the latest close the market valued the company at 15.86M SGD.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- 15.86M SGD
- P/E ratio
- –
- Price to sales
- 317.95
- Price to book
- 3.14
- Dividend yield
- –
- Free cash flow yield
- -57.94%
Fundamentals
- Revenue
- 49.89K SGD
- Net income
- -4.67M SGD
- EPS, diluted
- -22.83 SGD
- Free cash flow
- -9.19M SGD
Trading
- Previous close
- $1.72
- Open
- $1.67
- Day's range
- $1.67 – $1.74
- Volume
- 12,188
- Average volume (20 days)
- 124,764
- RSI (14 days)
- 39.0
- Volatility (1 year)
- 203.6%
- Relative volume
- 0.12×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CUPR | S&P 500 | Difference | CUPR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -18.4% | -2.7% | −15.8 pts | ||
| 3 months | -44.0% | -1.7% | −42.3 pts | ||
| Year to date | -47.5% | +11.9% | −59.4 pts | ||
| 1 year | -72.0% | +12.0% | −84.0 pts |
Five years at a glance
Fiscal years 2021 to 2025, SGD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Cuprina Holdings (Cayman) filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Cuprina Holdings (Cayman)
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Cuprina Holdings (Cayman) Limited is a biomedical and wound care company that develops, manufactures, and commercializes products for chronic wound management and skin health. The company operates across two principal segments: chronic wound care products and cosmeceutical products. Its flagship offerings include the MEDIFLY line of medical-grade sterile blowfly larvae bio-dressings for maggot debridement therapy, alongside a specialized range of cosmeceutical formulations. Cuprina serves institutional healthcare providers, including medical centers and hospitals, as well as individual consumers.
Company profile, executives and historyCuprina Holdings (Cayman) stock: common questions
What is Cuprina Holdings (Cayman)'s stock price?
CUPR closed at $1.68 on Nov 12, 2026, down 2.33% on the day.
What is Cuprina Holdings (Cayman)'s market cap?
Cuprina Holdings (Cayman) was worth $12.37M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is CUPR's P/E ratio?
Cuprina Holdings (Cayman) lost money over fiscal 2025 (diluted EPS -22.83 SGD), so it has no meaningful P/E ratio.
How much revenue does Cuprina Holdings (Cayman) make?
Cuprina Holdings (Cayman) reported revenue of 49.89K SGD for fiscal 2025, up 3.3% from a year earlier.
Does Cuprina Holdings (Cayman) pay a dividend?
No. Cuprina Holdings (Cayman) has not paid a cash dividend over the last twelve months.
How has CUPR stock performed over the past year?
Including dividends, CUPR returned -72.0% over the past year, against +12.0% for the S&P 500.
Who are Cuprina Holdings (Cayman)'s competitors?
Companies most similar to Cuprina Holdings (Cayman) by business, industry and size include YBGJ, GUTS, PFSA, RDGL, POAS.
See a number that looks wrong?